Embedded Files
WHO WE ARE
A cross-border partnership advancing precision oncology
BRIGHT-TNBC brings together leading researchers from Romania and the Republic of Moldova to develop innovative, biomarker-guided therapeutic strategies for triple-negative breast cancer (TNBC).
Our consortium combines expertise in proteomics, molecular pathology, translational oncology, and advanced preclinical modeling to address one of the most difficult challenges in breast cancer research.
OUR RESEARCH FOCUS
Transforming TNBC Research Through Collaboration
The project is coordinated by the “Iuliu Hațieganu” University of Medicine and Pharmacy (UMFIH), Cluj-Napoca, Romania, in strong collaboration with the “Nicolae Testemițanu” State University of Medicine and Pharmacy (USMF-NT), Chișinău, Moldova.
Together, we aim to accelerate the development of effective, affordable treatment options through scientific excellence, data-driven innovation, and meaningful knowledge exchange between our institutions.
RESEARCH LEADERSHIP AND TEAM MEMBERS
Leading the Development of Biomarker-Driven Strategies for TNBC
The BRIGHT-TNBC project is powered by a cross-border team of experts in proteomics, pathology, molecular oncology, and preclinical modeling. Our leadership brings together deep scientific expertise and complementary strengths from Romania and the Republic of Moldova.
Project
Director
Prof. Cristina-Adela Iuga
UMFIH (RO)
Project
Co-Director
Conf. Dr. Eugen Melnic
USMF-NT (MD)
Pathology
Aliona Nicorici
USMF-NT (MD)
IHC / Cytology
Mihaela Cozma
USMF-NT (MD)
Cell Culture
Ximena Mureșan
UMFIH (RO)
Proteomics
Ioana Pralea
UMFIH (RO)
Microscopy
Cristian Moldovan
UMFIH (RO)
In Vivo Models
Diana Tomuleasa
UMFIH (RO)
In Vivo
Imaging
Richard Feder
UMFIH (RO)
MS Sample Preparation
Andreea Ungur
UMFIH (RO)
Google Sites
Report abuse